[Product Releases]
|
|
|
|
|
[Blog]
|
|
Most recent post
|
[News]
|
|
Can we trust docking results?
Sept 2010 IBM Systems and Technology Group releases a white paper with eHiTS and Cell
Oct 2008
EPA's ToxCastTM project will use SimBioSys' eHiTS as docking engine
Nov, 2007
|
[Events]
|
| 243rd ACS
Mar 25-29, 2012
San Diego, CA
see >> more
|
|
|
|
|
SimBioSys Quarterly Newsletter
Winter
2006 Issue
|
|
In
this issue of the SimBioSys Quarterly Newsletter:
|
SimBioSys Releases eHiTS on
SUN Grid Compute Utility.
SimBioSys Inc., is pleased to announce its partnership with Sun
Microsystems, Inc. (NASDAQ: SUNW) to offer the most accurate, easy to
use and fast docking program, eHiTS, on the Sun Grid Compute Utility.
"We are excited to offer our software on the Sun Grid Compute Utility,"
said Zsolt Zsoldos, SimBioSys' President and Chief Scientific Officer.
"Our testing of eHiTS on the Sun Grid has shown impressive scalability
up to at least 100 CPUs. As a result, problems that used to run for
weeks can now be solved in days which allows the drug discovery
pipeline to be filled faster and with more leads."
See full press release on sun.com:
http://www.sun.com/smi/Press/sunflash/2006-11/sunflash.20061114.4.xml
If you are interested in Beta-testing eHiTS on SGCU, please sign up now
by contacting Aniko Simon (aniko/at/simbiosys.com), there are still a few
spots lefts. Beta-testing starts Dec 15th, 2006. Note: this
service is only available to US residents / customers.
|
SimBioSys
and Sun Microsystems to co-host docking /screening seminar series
To coincide with the
release of the Sun Grid Compute Utility (SGCU), SimBioSys and Sun are
cosponsoring two lunch seminars in the San Diego and San Francisco
areas. The events will focus on how to benefit from the vast
wealth of available compute power on the grid by performing docking
experiments with eHiTS. In addition, each session will have a
presentation from a user of the docking and screening tool discussing
their experiences.
January 17th, Sun Executive Briefing Center, Menlo Park
- Keynote: Dr. Osman Guner,
Turquoise Consulting
- Sun Keynote: Jim Parkinson
VP of engineering
January 18th, Tutto Mare Ristorante, San Diego
- Keynote: Dr. Nouri
Neamati, USC
- Sun Keynote: Jim Parkinson
VP of engineering
For more information about these events please check our web site:
http://www.simbiosys.com/science/presentations/lunch-seminar-2007/
|
Qon-Teq
becomes West Coast distributor of SimBioSys products
Based out of San
Diego, Qon-teq® offers Consultative Sales Services for Technology
Companies in the field of Life Sciences. The new deal with SimBioSys
permits Qon-Teq to sell SimBioSys products in the United States. This
partnership should increase the distribution of SimBioSys products and
improve the purchasing experience of clients.
SimBioSys, a leader in the area of drug discovery and synthetic
accessibility software, is very excited about this partnership.
We encourage those in the US interested in expanding their software
holdings to contact Qon-Teq and get in touch with a sales
representative.
info@qon-teq.com
Qon-teq, LLC
4370 La Jolla Village Drive Suite 400
San Diego, CA 92122, USA
http://www.qon-teq.com/
|
eHiTS
end-of-year offer (30% off)
2006 has been a very
good year for SimBioSys. In keeping with the company's focus on
science and developing new, leading edge software, SimBioSys has had a
banner year in terms of developing and releasing new and improved
products.
This year we released:
- eHiTS Score: a brand new statistically based empirical scoring
function.
- eHiTS Filter: a new ligand based screening tool which finds
similarity based on surface properties of ligands.
- eHiTS 6.1.5: there were three major releases of eHiTS this
year, each with increasing accuracy and better performance, culminating
in the 6.1.5 release.
- CheVi: a 3D molecular visualization program specifically
designed to show interactions between receptors and ligands in ways not
previously seen. This tool is available to everyone FREE of charge.
- ARChem Route Designer: a tool to assist chemists in developing
the synthesis scheme for a target molecule by automated retrosynthetic
analysis.
At SimBioSys, we are very proud of our accomplishments in 2006 and we
feel you could benefit from incorporating these and other SimBioSys
products in your daily work. Therefore we would like to offer you
30% off the first year price of any of the above mentioned products if
you decide to purchase by the end of the year.
|
|
|
|
[Newsletters]
|
|
|
[Stay informed]
|
|
|
|
